논문KCI 등재
Steatotic liver disease in chronic hepatitis C related hepatocellular carcinoma: Inflictor or bystander?: Correspondence to editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
참고문헌 (11)
관련 논문AI추천
Letter to the editor on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Hai Xu, Huikun Wu, Yong Zhou대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to letter to the editor 1 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Sang Min Park, Seogsong Jeong, Won Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호Correspondence to letter to the editor 2 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”Sang Min Park, Seogsong Jeong, Won Kim대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제2호MASLD after hepatitis C virus eradication: Do not overlook the cardiometabolic risk factors: Editorial on “Dynamic change of metabolic dysfunction-associated steatotic liver disease in chronic hepatitis C patients after viral eradication: A nationwide registry study in Taiwan”Lung-Yi Mak, Rex Wan-Hin Hui대한간학회 · Clinical and Molecular Hepatology2025 · 제31권 제1호Metabolic dysfunction-associated fatty liver disease is a ubiquitous latent cofactor in viral- and alcoholic-related hepatocellular carcinoma: Editorial on “Global prevalence of metabolic dysfunction-associated fatty liver disease-related hepatocellular carcinoma: A systematic review and meta-analysis”Keisuke Amano, Masahito Nakano, Takumi Kawaguchi, Toru Nakamura, Tsubasa Tsutsumi대한간학회 · Clinical and Molecular Hepatology2024 · 제30권 제4호Should direct-acting antiviral be considered for all pa tients with HCV-related hepatocellular carcinoma?: Reply to correspondence on “Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study”Apichat Kaewdech, Yan Ling Ong, Yu Jun Wong대한간학회 · Clinical and Molecular Hepatology2026 · 제32권 제1호
이 간행물의 다른 논문 (84건)
Roles of X-box binding protein 1 in liver pathogenesisYun Seok Kim, Jihoon Tak, Sang Geon Kimpp. 1-31Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screeningTian Xia, Jiawen Wangpp. 1-2KASL clinical practice guidelines for the management of metabolic dysfunction-associated steatotic liver disease 2025Eun Joo Lee, Jung Hee Kim, Byoung Kuk Jang, Miyoung Choi, Su Jong Yu, Young-Sun Lee, Young-Joo Jin, Hye Won Lee, Soon Sun Kim, Pil Soo Sung, Young Kul Jung, Gi-Ae Kim, Young Chang, Won Sohn, Jeong-ju Yoopp. 1-31Comparison of the therapeutic effects of transarterial radioembolization and tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosisHua Lu, Xiao-Song Li, Xi-Ping Shen, Hang Lipp. 3-4Contemporary awareness of viral hepatitis between 2012 and 2022 among Korean adultsDonghee Kim, Aijaz Ahmed, Won Kimpp. 5-7